Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Thromboembolism in Multiple Myeloma: A Single Centre Retrospective Review

Alvin Ka Nok Liu, Jason Tay

Blood (2024) 144 (Supplement 1): 6923.

https://doi.org/10.1182/blood-2024-204683

Published: 2024

Journal Articles

Immunome Single Cell Profiling Reveals T Cell Exhaustion with Upregulation of Checkpoint Inhibitors LAG3 and Tigit on Marrow Infiltrating T Lymphocytes in Daratumumab and IMiDs Resistant Patients

Paola Neri, MD, Ranjan Maity, PhD, Ines Tagoug, PhD, Sylvia McCulloch, MD, Peter Duggan, MD, Victor Jimenez-Zepeda, MD, Jason Tay, MD, Anjan Thakurta, PhD, Nizar Bahlis, MD

Blood (2018) 132 (Supplement 1): 242.

https://doi.org/10.1182/blood-2018-99-117531

Published: 2018

Journal Articles

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Holly Lee, MD, Lesley Street, MD, Jason Tay, MD, Jennifer Grossman, MD, John F Thaell, MD, Dawn Goodyear, MD, Sylvia McCulloch, MD, Peter Duggan, MD, Paola Neri, MD, Victor Jimenez-Zepeda, MD

Blood (2018) 132 (Supplement 1): 4495.

https://doi.org/10.1182/blood-2018-99-117819

Published: 2018

Journal Articles

Monoclonal Gammopathy of Undetermined Significance - Patient Characteristics and Referral Patterns

Holly Lee, MD, Lesley Street, MD, Jason Tay, MD, Jennifer Grossman, MD, John F Thaell, MD, Dawn Goodyear, MD, Sylvia McCulloch, MD, Peter Duggan, MD, Paola Neri, MD, Victor Jimenez-Zepeda, MD

Blood (2018) 132 (Supplement 1): 4496.

https://doi.org/10.1182/blood-2018-99-117930

Published: 2018

Journal Articles

Identification of Specificity Groups in Myeloma Patients T Cell Receptor (TCR) Repertoire through Single Cell TCR Sequencing

Paola Neri, MD, Ranjan Maity, PhD, Sylvia McCulloch, MD, Peter Duggan, MD, Victor Jimenez-Zepeda, MD, Jason Tay, MD, Nizar Bahlis, MD

Blood (2018) 132 (Supplement 1): 4459.

https://doi.org/10.1182/blood-2018-99-117482

Published: 2018

Journal Articles

Economics of Multiple Myeloma

Rachel Wong, BSc, MD, Jason Tay, MD

Blood (2018) 132 (Supplement 1): 4773.

https://doi.org/10.1182/blood-2018-99-110140

Published: 2018

Journal Articles

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Jason Tay, MD, Ruta Brazauskas, PhD, Naya He, Sara Beattie, Christopher Bredeson, MD FRCPC, MSc, Jignesh Dalal, MD, Shahrukh K. Hashmi, MD MPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 4788.

https://doi.org/10.1182/blood-2018-99-117027

Published: 2018

Journal Articles

Impact of Active Maintenance Treatment (MT) Compared to No MT on the Quality of Life (QoL) of Patients with Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT)

Jason Tay, MD FRCPC, Ravi Vij, MDMBA, Maxim Norkin, MD, Shaji K Kumar, MD, Tamila L Kindwall-Keller, DO, Jenna S Roberts, PhD, Darrell J White, MD, Robert P Wood, BSc, Sophee E Blanthorn-Hazell, MSc, BSc, Adriana C. Rossi, MDMSc, Sujith Dhanasiri, MSc, Faiza Zafar, MPAS, Kim Newhouse, BSc. , BScN, McCurdy R Arleigh, MD MHA, FRCPC

Blood (2017) 130 (Supplement 1): 2150.

https://doi.org/10.1182/blood.V130.Suppl_1.2150.2150

Published: 2017

Journal Articles

Minimal Residual Disease (MRD) Assessed By Flow Cytometry in Patients with AL Amyloidosis Treated with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD)

Victor Jimenez-Zepeda, MD, Peter Duggan, MD FRCPC, Paola Neri, MD, Jason Tay, MD FRCPC, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 1836.

https://doi.org/10.1182/blood.V130.Suppl_1.1836.1836

Published: 2017

Journal Articles

Early Relapse in Transplant-Eligible MM Patients Undergoing Auto-SCT Followed By Maintenance Therapy

Victor Jimenez-Zepeda, MD, Peter Duggan, MD FRCPC, Paola Neri, MD, Jason Tay, MD FRCPC, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 5523.

https://doi.org/10.1182/blood.V130.Suppl_1.5523.5523

Published: 2017

Journal Articles

Post-Autologous Stem Cell Transplantation Therapy for Multiple Myeloma Patients: Impact on Clinical Outcomes

Victor Jimenez-Zepeda, MD, Peter Duggan, MD FRCPC, Paola Neri, MD, Jason Tay, MD FRCPC, Sylvia McCulloch, MD, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 5524.

https://doi.org/10.1182/blood.V130.Suppl_1.5524.5524

Published: 2017

Journal Articles

Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)

Paola Neri, MD, Ranjan Maity, PhD, Ines Tagoug, PhD, Peter Duggan, MD FRCPC, Sylvia McCulloch, MD, Victor Jimenez-Zepeda, MD, Jason Tay, MD FRCPC, Lawrence H. Boise, PhD, Anjan Thakurta, PhD, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 123.

https://doi.org/10.1182/blood.V130.Suppl_1.123.123

Published: 2017

Journal Articles

The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort

Zack M. Breckenridge, BSc, Victor Jimenez-Zepeda, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Ismail Ismail, Jason Tay, MD FRCPC, Peter Duggan, MD FRCPC, Andrew Belch, Joanne D. Hewitt, NP, PhD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner

Blood (2017) 130 (Supplement 1): 1859.

https://doi.org/10.1182/blood.V130.Suppl_1.1859.1859

Published: 2017

Journal Articles

Bortezomib-Maintenance for Patients with AL Amyloidosis: A Single Center Experience

Victor Jimenez-Zepeda, MD, Peter Duggan, MD FRCPC, Paola Neri, MD, Jason Tay, MD FRCPC, Nizar J. Bahlis, MD

Blood (2017) 130 (Supplement 1): 3151.

https://doi.org/10.1182/blood.V130.Suppl_1.3151.3151

Published: 2017

Journal Articles

Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds

Jason Tay, MDFRCPC MSc, David S. Allan, MD FRCPC, Elizabeth Chatelain, Doug Coyle, Mohamed Elemary, MD MSc,PhD, William Petrcich, Timothy Ramsay, Alan Tinmouth, MD FRCPC, Irwin Walker, MBBS, Anargyros Xenocostas, MD, Dean Fergusson, MHA, PhD

Blood (2016) 128 (22): 1032.

https://doi.org/10.1182/blood.V128.22.1032.1032

Published: 2016

Journal Articles

Immunoglobulin Recovery after ASCT for Patients with Multiple Myeloma: Impact on Overall Survival and Progression-Free Survival

Victor Jimenez-Zepeda, MD, Peter Duggan, MD, Paola Neri, MD PhD, Ahsan Chaudhry, MD, Jason Tay, MDFRCPC MSc, Nizar J. Bahlis, MD

Blood (2016) 128 (22): 2263.

https://doi.org/10.1182/blood.V128.22.2263.2263

Published: 2016

Journal Articles

High-Risk Cytogenetics Multiple Myeloma: Impact of Consolidation and Maintenance

Victor Jimenez-Zepeda, MD, Peter Duggan, MD, Paola Neri, MD PhD, Jason Tay, MDFRCPC MSc, Fariborz Rashid-Kolvear, PhD, Nizar J. Bahlis, MD

Blood (2016) 128 (22): 2271.

https://doi.org/10.1182/blood.V128.22.2271.2271

Published: 2016

Journal Articles

Bortezomib-High Dose Melphalan Conditioning for the Treatment of MM Patients Undergoing ASCT

Victor Jimenez-Zepeda, MD, Peter Duggan, MD, Paola Neri, MD PhD, Ahsan Chaudhry, MD, Jason Tay, MDFRCPC MSc, Joanne Luider, Nizar J. Bahlis, MD

Blood (2016) 128 (22): 2273.

https://doi.org/10.1182/blood.V128.22.2273.2273

Published: 2016

Journal Articles

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Bortezomib, Thalidomide and Dexamethasone (VTD) As Induction Therapy for the Treatment of Transplant Eligible Multiple Myeloma

Victor Jimenez-Zepeda, MD, Nizar J. Bahlis, MD, Peter Duggan, MD, Rafael Alonso, MD, Juan José Lahuerta, MD PhD, Antonio Valeri, Paola Neri, MD PhD, Jason Tay, MD FRCPC MSc, Joaquin Martinez-Lopez

Blood (2016) 128 (22): 4505.

https://doi.org/10.1182/blood.V128.22.4505.4505

Published: 2016

Journal Articles

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Alissa Visram, MD, Natasha Kekre, MD MPH, FRCPC, Christopher N. Bredeson, MD MSc, FRCPC, Jason Tay, MDFRCPC MSc, Lothar B. Huebsch, MD, Sheryl McDiarmid, Ranjeeta Mallick, PhD, Mitchell Sabloff, MDM, Harold Atkins, MDFRCPC, David S. Allan, MD FRCPC, Alan Tinmouth, MD FRCPC, Linda Hamelin, Lisa Martin, Dawn Maze, MD FRCPC MSc

Blood (2016) 128 (22): 2186.

https://doi.org/10.1182/blood.V128.22.2186.2186

Published: 2016

NARROW

Thromboembolism in Multiple Myeloma: A Single Centre Retrospective Review

Immunome Single Cell Profiling Reveals T Cell Exhaustion with Upregulation of Checkpoint Inhibitors LAG3 and Tigit on Marrow Infiltrating T Lymphocytes in Daratumumab and IMiDs Resistant Patients

Monoclonal Gammopathy of Clinical Significance - a Single Center Experience

Monoclonal Gammopathy of Undetermined Significance - Patient Characteristics and Referral Patterns

Identification of Specificity Groups in Myeloma Patients T Cell Receptor (TCR) Repertoire through Single Cell TCR Sequencing

Economics of Multiple Myeloma

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Impact of Active Maintenance Treatment (MT) Compared to No MT on the Quality of Life (QoL) of Patients with Multiple Myeloma (MM) Following First Autologous Stem Cell Transplant (ASCT)

Minimal Residual Disease (MRD) Assessed By Flow Cytometry in Patients with AL Amyloidosis Treated with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD)

Early Relapse in Transplant-Eligible MM Patients Undergoing Auto-SCT Followed By Maintenance Therapy

Post-Autologous Stem Cell Transplantation Therapy for Multiple Myeloma Patients: Impact on Clinical Outcomes

Single Cell Resolution Profiling Defines the Innate and Adaptive Immune Repertoires Modulated By Daratumumab and IMiDs Treatment in Multiple Myeloma (MM)

The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort

Bortezomib-Maintenance for Patients with AL Amyloidosis: A Single Center Experience

Transfusion of Red Cells in Hematopoietic Stem Cell Transplantation (TRIST Study): A Randomized Controlled Trial Evaluating 2 Red Cell Transfusion Thresholds

Immunoglobulin Recovery after ASCT for Patients with Multiple Myeloma: Impact on Overall Survival and Progression-Free Survival

High-Risk Cytogenetics Multiple Myeloma: Impact of Consolidation and Maintenance

Bortezomib-High Dose Melphalan Conditioning for the Treatment of MM Patients Undergoing ASCT

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Bortezomib, Thalidomide and Dexamethasone (VTD) As Induction Therapy for the Treatment of Transplant Eligible Multiple Myeloma

Factors Influencing Long-Term Hematopoietic Function Following Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only